Lumora Ltd. and 3M have signed a joint development and licensing agreement, under which 3M will develop and sell nucleic acid test kits using Lumora’s BART technology. Lumora specializes in the development of “robust, affordable and easy-to use molecular diagnostics systems,” based on its BART (Bioluminescent Assay in Real-Time) technology. BART is a reporter system for use with isothermal nucleic acid amplification technologies, and is used as a tool in molecular diagnostics. The company, foun...